NPI: 1265477889 · NEW YORK, NY 10032 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/18/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (ASSISTANT SECRETARY) |
| NPI Enumeration Date | 06/18/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,775 | $83K |
| 2019 | 2,355 | $21K |
| 2020 | 14,884 | $75K |
| 2021 | 7,905 | $102K |
| 2022 | 10,707 | $345K |
| 2023 | 6,269 | $347K |
| 2024 | 1,492 | $138K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 7,357 | 701 | $788K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 28,704 | 1,013 | $176K |
| A4657 | Syringe, with or without needle, each | 8,428 | 1,418 | $137K |
| J1270 | Injection, doxercalciferol, 1 mcg | 1,185 | 95 | $6K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 207 | 79 | $2K |
| 82728 | 1,368 | 135 | $1K | |
| 82108 | 378 | 31 | $423.48 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 68 | 14 | $322.28 |
| 83970 | 329 | 44 | $312.59 | |
| 85041 | 142 | 24 | $110.54 | |
| J1756 | Injection, iron sucrose, 1 mg | 221 | 52 | $0.00 |